Join BioCentriq at BioNJ’s Virtual Manufacturing Briefing: Pandemic-Induced Innovation & Adaption! Taking place Sept. 29. Learn More.

BioCentriq will be on site in Miami at the Advanced Therapies Week event and look forward to meeting you there!

BioCentriq will be attending the Advanced Therapies Connect event on September 28th and 29th and looks forward to meeting many of you there.

BioCentriq is sponsoring Meeting on the Mesa and will be available both on-site and in person to meet with clients.

Identifying Priorities in Early Stage for Manufacturing Success. Learn from the experts how to strategize in early stages to success in commercializing cell and gene therapy products.

Join us for a panel discussion with leaders from higher education and industry to listen and learn about how these two groups can unite to identify and operationalize innovations that create industry advancements. Our esteemed …

BioCentriq, our Biopharma Division, will be part of this year’s on-demand global showcase starting on May 26th. We will also be attending the event and sharing a poster from a recent project.

Join us online on April 29th at 12pm EDT to learn all about BioCentriq, a state of the art cell and gene therapy process development and clinical manufacturing center located in New Jersey.During this session …

A 4-day online virtual training course in upstream and downstream processing of viral vectors used in cell and gene therapy. The course will focus on viral vector theory, technical demonstrations of bioreactors, demonstration of chromatography, …

Please join Joseph Tarnowski, SVP, Cell & Gene Therapy, R&D Medicinal Science and Technology at GSK, Hari Pujar, Ph.D., Operating Partner at Flagship Pioneering, Haro Hartounian, Ph.D., SVP & General Manager, BioCentriq and Michael Lehmicke, …

A 4-day online virtual training course in upstream and downstream processing of viral vectors used in cell and gene therapy. The course will focus on viral vector theory, technical demonstrations of bioreactors, demonstration of chromatography, …

Alex Klarer, Head of Cell Therapy Development at BioCentriq will be speaking.